Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 16, 2016 - Issue 1
Submit an article Journal homepage
934
Views
32
CrossRef citations to date
0
Altmetric
Reviews

Diagnosis and therapy of acute disseminated encephalomyelitis and its variants

Giulia BerzeroC. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy;Neuroscience Consortium, University of Pavia, Monza Policlinico and Pavia Mondino, Pavia, Italy
,
Andrea CorteseC. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy
,
Sabrina RavagliaC. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy
&
Enrico MarchioniC. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, ItalyCorrespondence[email protected]
Pages 83-101 | Published online: 22 Dec 2015

References

•• The largest prospective study on post-infectious encephalomyelitis to date, it reports a subgroup of 64 patients with combined central and peripheral demyelination and poorer outcome.

  • Panicker JN, Nagaraja D, Kovoor JM, et al. Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med. 2010;56(1):12–16.

• A large prospective study on any-age ADEM patients that reports in detail the clinical and paraclinical features of the cohort.

  • Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56(10):1313–1318.
  • De Seze J, Debouverie M, Zephir H, et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007;64(10):1426–1432.
  • Ketelslegers IA, Visser IE, Neuteboom RF, et al. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler. 2011;17(4):441–448.
  • Lin CH, Jeng JS, Hsieh ST, et al. Acute disseminated encephalomyelitis: a follow-up study in Taiwan. J Neurol Neurosurg Psychiatry. 2007;78(2):162–167.
  • Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004;23(8):756–764.
  • Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002;59(8):1224–1231.

•• A large prospective series that is considered the pivotal study on pediatric ADEM patients.

  • Idrissova Z, Boldyreva MN, Dekonenko EP, et al. Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol. 2003;10(5):537–546.
  • Anlar B, Basaran C, Kose G, et al. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics. 2003;34(4):194–199.
  • Hung KL, Liao HT, Tsai ML. The spectrum of postinfectious encephalomyelitis. Brain Dev. 2001;23(1):42–45.
  • Dale RC, De Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123(Pt 12):2407–2422.
  • Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56(10):1308–1312.
  • Singhi PD, Ray M, Singhi S, et al. Acute disseminated encephalomyelitis in North Indian children: clinical profile and follow-up. J Child Neurol. 2006;21(10):851–857.
  • Mikaeloff Y, Caridade G, Husson B, et al. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol. 2007;11(2):90–95.
  • Adamovic T, Riou EM, Bernard G, et al. Acute combined central and peripheral nervous system demyelination in children. Pediatr Neurol. 2008;39(5):307–316.

•• An original report of 13 children with CCPD and poor clinical outcome.

  • Ogata H, Matsuse D, Yamasaki R, et al. A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry. 2015;pii:jnnp-2014-309831.

• A recent nationwide survey that sets the CCPD phenomenon into a population context.

  • DeSena A, Graves D, Morriss MC, et al. Transverse myelitis plus syndrome and acute disseminated encephalomyelitis plus syndrome: a case series of 5 children. JAMA Neurol. 2014;71(5):624–629.

• A detailed description of 5 pediatric cases of CCPD.

  • Zéphir H, Stojkovic T, Latour P, et al. Relapsing demyelinating disease affecting both the central and peripheral nervous systems. J Neurol Neurosurg Psychiatry. 2008;79(9):1032–1039.
  • Martens-Le Bouar H, Korinthenberg R. Polyradiculoneuritis with myelitis: a rare differential diagnosis of Guillain-Barré syndrome. Neuropediatrics. 2002;33(2):93–96.
  • Pohl D, Hennemuth I, Von Kries R, et al. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr. 2007;166(5):405–412.
  • Torisu H, Kira R, Ishizaki Y, et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev. 2010;32(6):454–462.
  • Pellegrino P, Radice S, Clementi E. Geoepidemiology of acute disseminated encephalomyelitis. Epidemiology. 2014;25(6):928–929.
  • Murthy SN, Faden HS, Cohen ME, et al. Acute disseminated encephalomyelitis in children. Pediatrics. 2002;110(2 Pt 1):e21.
  • Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Arch Neurol. 2005;62(11):1673–1680.
  • Murray BJ, Apetauerova D, Scammell TE. Severe acute disseminated encephalomyelitis with normal MRI at presentation. Neurology. 2000;55(8):1237–1238.
  • Lakhan SE. Teaching neuroimages: MRI time lag with acute disseminated encephalomyelitis. Neurology. 2012;78(22):e138–9.
  • Bennetto L, Scolding N. Inflammatory/post-infectious encephalomyelitis. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):i22–8.
  • Tenembaum SN. Disseminated encephalomyelitis in children. Clin Neurol Neurosurg. 2008;110(9):928–938.
  • Franciotta D, Columba-Cabezas S, Andreoni L, et al. Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol. 2008;200(1–2):125–128.

• An interesting study on the different OCB patterns observed in inflammatory demyelinating disorders and their possible relation to disease pathogenesis.

  • O’Riordan JI, Gomez-Anson B, Moseley IF, et al. Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci. 1999;167(2):132–136.
  • Marchioni E, Ravaglia S, Piccolo G, et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology. 2005;65(7):1057–1065.

• The first prospective study on postinfectious encephalomyelitis to evidence the existence of variants characterized by site-restricted damage or additional PNS involvement.

  • Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006;180(1–2):17–28.
  • Grigoriadis N, Van Pesch V. A basic overview of multiple sclerosis immunopathology. Eur J Neurol. 2015;Oct;22(Suppl 2):3–13.
  • Franciotta D, Zardini E, Ravaglia S, et al. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci. 2006;247(2):202–207.

• This study provides useful elements to the in-depth understanding of ADEM pathogenesis.

  • Popescu BF, Lucchinetti CF. Pathology of demyelinating diseases. Annu Rev Pathol. 2012;7(185):217.
  • Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry. 1975;38(6):585–591.
  • Habek M, Zarkovic K. Pathology of acute disseminated encephalomyelitis. Translational Neuroscience. 2011;2(3):252–255.
  • Young NP, Weinshenker BG, Parisi JE, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain. 2010;133(Pt 2):333–348.

• A comprehensive description of the distinctive neuropathological features of ADEM.

  • Kamm C, Zettl UK. Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev. 2012;11(3):196–202.
  • Kawamura N, Yamasaki R, Yonekawa T, et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology. 2013;81(8):714–722.
  • Van Berge L, Hamilton EM, Linnankivi T, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain. 2014;137(Pt 4):1019–1029.
  • Wolf NI, Toro C, Kister I, et al. DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder. Neurology. 2015;84(3):226–230.
  • Tavazzi E, Ravaglia S, Franciotta D, et al. Differential diagnosis between acute disseminated encephalomyelitis and multiple sclerosis during the first episode. Arch Neurol. 2008;65(5):676–677.
  • Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev. 2012;245(1):227–238.
  • Menge T, Kieseier BC, Nessler S, et al. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol. 2007;20(3):247–254.
  • Ishizu T, Minohara M, Ichiyama T, et al. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol. 2006;175(1–2):52–58.

• This study provides useful elements to the in-depth understanding of ADEM pathogenesis.

  • Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86(3):265–272.
  • Di Pauli F, Mader S, Rostasy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011;138(3):247–254.
  • Hacohen Y, Absoud M, Woodhall M, et al. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry. 2014;85(4):456–461.
  • Van Haren K, Tomooka BH, Kidd BA, et al. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler. 2013;19(13):1726–1733.
  • Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014;82(10):879–886.
  • Shima S, Kawamura N, Ishikawa T, et al. Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy. Neurology. 2014;82(2):114–118.
  • Neilson DE, Adams MD, Orr CMD, et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84(1):44–51.
  • Disanto G, Magalhaes S, Handel AE, et al. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology. 2011;76(9):781–786.
  • International Multiple Sclerosis genetic Consortium (IMSGC). Analysis of immune-related loci identified. 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353–1360.
  • Van Pelt ED, Mescheriakova JY, Makhani N, et al. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology. 2013;81(23):1996–2001.
  • Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol. 2012;14(3):264–275.
  • Shahar E, Andraus J, Savitzki D, et al. Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol. 2002;17(11):810–814.
  • Apak RA, Anlar B, Saatci I. A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev. 1999;21(4):279–282.
  • Sahlas DJ, Miller SP, Guerin M, et al. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000;54(6):1370–1372.
  • Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol. 2002;249(1):100–104.
  • Ravaglia S, Piccolo G, Ceroni M, et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol. 2007;254(11):1518–1523.
  • Nishikawa M, Ichiyama T, Hayashi T, et al. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. 1999;21(2):583–586.
  • Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58(1):143–146.
  • Suppiej A, Cainelli E, Casara G, et al. Long-term neurocognitive outcome and quality of life in pediatric acute disseminated encephalomyelitis. Pediatr Neurol. 2014;50(4):363–367.
  • Hahn CD, Miles BS, MacGregor DL, et al. Neurocognitive outcome after acute disseminated encephalomyelitis. Pediatr Neurol. 2003;29(2):117–123.
  • Mikaeloff Y, Suissa S, Vallée L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr. 2004;144(2):246–252.
  • Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain. 2004;127(Pt 9):1942–1947.
  • Krupp LB, Banwell B, Tenembaum S, International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68:16 Suppl 2S7–12.
  • Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261–1267.

•• The latest Consensus definitions proposed for ADEM in the pediatric cohort.

  • Peche SS, Alshekhlee A, Kelly J, et al. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol. 2013;49(5):329–334.
  • Naismith RT, Banwell BL. Can “dissemination” include the PNS in adults with acute disseminated encephalomyelitis?. Neurology. 2013;80(10):876–877.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.